Understanding who benefits most from different psychotherapies for depression and anxiety
Official title: Understanding the Person, Exploring Change Across Psychotherapies
Run by Institute of Mental Health, Singapore · NCT04106713 · Data updated 2026-11-12
This study tests how people with depression or anxiety respond to individual therapy, group therapy, or internet-based CBT to help clinicians tailor care.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 99 Years |
| Sex | All |
| Enrollment | 250 (estimated) |
| Sponsor | Institute of Mental Health, Singapore Academic / other |
| Locations | 1 site (Singapore, Singapore) |
| Status | Recruiting |
| Started | October 4, 2019 |
| Main results expected | September 30, 2026 |
| Study ends | September 30, 2026 |
| Registry record updated | August 6, 2026 |
| Trial ID | NCT04106713 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults 18–99 with current or past anxiety or depressive symptoms who can read and communicate in English and provide informed consent.
✕Probably not a fit
Patients not seeking psychotherapy or those who do not engage with the assigned intervention may not experience benefits.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This trial examines predictors of response to three psychotherapy formats—individual therapy, group CBT, and internet-delivered CBT—in patients with depression and anxiety. Participants are allocated to one of these interventions, a delayed waitlist, or treatment as usual, with data collection aimed at identifying factors that influence treatment outcomes. The setting is IMH Singapore, leveraging routine referrals and triage to understand real-world applicability. The study will explore potential biological and psychosocial predictors that could guide right-siting and personalization of care. Recruitment targets all outpatients referred for psychotherapy at the institute who meet eligibility.
Why it matters
Potential benefit: If successful, the findings could improve referral decisions and personalize psychotherapy choices to maximize benefit for patients.
How similar studies have gone: Prior research shows that response to psychotherapy varies by modality, but this study is among the first in this setting to link predictors to multiple formats.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria:
1. For patients:
1. 18-99 years old;
2. have current or past symptoms of anxiety and/or depression;
3. able to communicate and read in English;
4. able to provide informed consent.
5. Waitlist arm:
\- Referred for psychotherapy but given a waiting time of 8 weeks or more to the first visit or not assigned to therapy at IMH.
6. Treatment as usual:
\- Not assigned to any psychotherapeutic interventions.
7. iCBT: - Referred for iCBT;
\- Identified as a 'P2' patient/appropriate for iCBT by triage.
8. Group therapy:
\- Referred for group therapy;
\- Identified as a 'P2' patient/appropriate for group therapy by triage.
9. Individual psychotherapy:
* Referred for individual therapy;
* Patient and therapist committed to frequent therapy (ideally fortnightly).
2. For therapists:
1. Therapists who will see OR have been assigned to clients in the waitlist arm, iCBT, group therapy (e.g. PsychUp), and individual psychotherapy group.
Exclusion Criteria:
1\. For patients:
1. current active suicidal intention or plan;
2. cognitively-impaired/are unable to consent/lack capacity to consent.
Where it's running
-
Institute of Mental Health, Singapore
Singapore, Singapore, Singapore Recruiting
Study contacts
- Principal investigator: Geoffrey CY Tan — Institute of Mental Health, Singapore
- Study coordinator: Geoffrey CY Tan
- Email: geoffrey_tan@imh.com.sg
- Phone: +65 63891923
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Brain stimulation for anxiety and depression in children and teens
This program will try transcranial magnetic stimulation (TMS) to see if it reduces anxiety and depression in children and teens aged 6 to 18 who are referred by their doctors.
-
Evaluating mentalization-based psychotherapy for anxiety and depression
This study is testing a new group therapy called mentalization-based psychotherapy to see if it helps people with anxiety and depression feel better compared to standard therapy.
-
Cognitive training for anxiety, depression, and PTSD
This study is testing a brain training program to see if it can help people with anxiety, depression, or PTSD think more clearly and feel better.
-
Investigating brain responses to threats in anxiety and depression
This study is testing how an anti-anxiety medication affects the brain's response to threats in people with anxiety, depression, or both to better understand their differences and improve treatments.
-
Using RxWell to Reduce Opioid Use After Knee or Hip Surgery
This study is testing whether a digital tool called RxWell can help people with mood disorders who are having knee or hip surgery reduce their opioid use and improve their mental health after the operation.
-
Exploring factors influencing anxiety and depression
This study looks at how different thoughts, feelings, biology, and social support affect anxiety and depression to help improve treatment for those struggling with these conditions.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.